SlideShare a Scribd company logo
RHEUMATOID ARTHRITIS(RA)
Learning objectives:
 At the end of this lecture the student should be able
to :
 understand definition,genetic predisposition of RA.
 Discuss pathophysiology, clinical features of RA.
 Identify Diagnostic Criteria ,Laboratory Features
and bad prognostic Features of Rheumatoid
Arthritis.
Definition
 Rheumatoid arthritis (RA) is a chronic systemic
inflammatory disorder that may affect many
tissues and organs—skin, blood vessels, heart,
lungs, and muscles—but principally attacks the
joints, producing a non-suppurative proliferative
and inflammatory synovitis that often progresses
to destruction of the articular cartilage and
ankylosis of the joints.
 Although the cause of RA remains
unknown, autoimmunity plays a pivotal
role in its chronicity and progression.
 About 1% of the world's population is
afflicted by RA, women two to three times
more often than men.
 It is most common in those age 40 to 70,
but no age is immune.
 It is a systemic inflammatory autoimmune
disorder
Genetics
 Patients who have HLA-DRB have
Increased risk for :
RA development.
Increased joint damage
Increased joint need for surgery
PATHOPHYSIOLOGY
Role of Immunology in RA
 Macrophages:
Produce cytokines
Cytokines (TNF-α) cause systemic
features
Release chemokines  recruit PMNs
into synovial fluid/membrane
 TNF-α & IL-1:
Proliferation of T cells
Activation of B cells
Initiates pro-inflammatory/joint-damaging
processes
 TH-1 cells:
Mediate disease processes
Activate B cells
 B cells:
Release cytokines
Plasma cells that produce Ab
 Osteoclasts induce:
Bone erosion
Juxta-articular & Systemic
osteoporosis
Pathophysiology
 Swelling of Synovial lining
 Angiogenesis
 Pannus formation in form of :
 Synovial thickening/hyperplasia
 Inflammatory vascularized tissue
 Generation of Metalloproteinases
 Cytokine release
 Infiltration of leukocytes
 Change in cell-surface adhesion molecules &
cytokines
 Destruction of bone & cartilage
Sequence of events :
 Proliferation of synovial membrane
cells with inflammatory cell infiltrate
 Destruction of joints
 Disability
DIAGNOSIS:
1- CLINICAL CRITERIA
2- INVESTIGATIONS
1- Diagnostic Criteria
 Symmetric peripheral polyarthritis
 Morning Stiffness >1 hour
 Extra-articular manifestations
 Rheumatoid nodules
Symmetric Peripheral
Polyarthritis
 3 or more Joints for >6 weeks
 Intermittent or Migratory involvement
 Small Joints
Hands & Feet
Peripheral to Proximal
 Leads to Deformity & Destruction of Joints
Erosion of cartilage and bone
Stiffness
 Morning or after Prolonged Inactivity
 Bilateral
 > 1 hours
Reflects severe joint inflammation
 Better with movement
 Pain with pressure to joint
….Stiffness
 Pain with movement of joint
 Swelling due to hypertrophy of
synovium
 Effusion
 Hotness
 Redness
Physical Exam
 Decreased grip strength
 Carpal tunnel syndrome(condition
characterized by pain and numbing or tingling
sensations in the hand and caused by
compression of a nerve in the carpal tunnel at
the wrist.
 Ulnar deviation
 Boutonniere/Swan neck deformities
 Extensor tendon rupture
Extraarticular Involvement
 Myalgia, fatigue, low-grade fever,
weight loss, depression.
 Anemia
 Rheumatoid nodules
 Pleuro-pericarditis
 Neuropathy
 Sicca features: Xerostomia &
Xerophthalmia
 Scleritis
 Splenomegaly
 Vasculitis
Xerostomia (Dry Mouth)
Xerophthalmia (Dry Eyes)
Rheumatoid Nodules
 Extensor surfaces
 elbows
 Very Specific
 Only occur in ~30%
 Late in Disease
Rheumatoid Vasculitis
RA Deformities
Investigations
Arthrocentesis
 Confirm diagnoses
 Differentiate between inflammatory &
non-inflammatory
 Labs:
White blood cell count if WBC
>2000/µL indicates inflammatory
arthritis
Gram stain & Culture
 Arthroscopy
Evaluate ligamentous &
cartilaginous integrity
Biopsy
Infection: aspirate thick
Rheumatoid arthritis : showing inflammatory cell
infiltrate in the synovium
Laboratory findings
 Anemia of moderate degree
 ESR  a useful parameter for assessing
response to therapy
 C-reactive protein 
 RF (usually IgM)
 CIC  , complements 
 ANA
 Anti-CCP (cyclic citrullinated peptide)
Rheumatoid Factor
 Antibodies to Fc portion of IgG
 75-80% of Patients have during
course of disease
 Useful for prognosis
Rheumatoid
Factor
 IgG Molecule
 Fc Portion
Antigen Binding
Groove
Autoantibodies (IgM)
directed against the
Fc Fragment of IgG
An Antibody to an
Antibody
Their Role in RA is
not understood
Rheumatoid Factor
 RFs are human auto-Abs that react with
the Fc portion of normal polyclonal IgG.
 Most routine clinical assays for RF detect
only IgM RFs, although RFs can be any
class of immunoglobulin
 Named thus because their first description
was in patients with rheumatoid arthritis
Rheumatoid Factor
 RF test is approximately 65%-75%
sensitive for the diagnosis
 The presence of RF, even in high titers or
large amounts, is not specific for RA
Condition Assoc . With(+) Tests for RF
 Rheumatologic Diseases
 Rheumatoid arthritis (~70%)
 Sjögren’s syndrome (~90%)
 Lupus (~20%)
 Cryoglobulinemia syndrome (90%)
 Lung Diseases
 Interstitial fibrosis
 Silicosis
 Infections
 Hepatitis C virus
 Acute viral infections
 Endocarditis
 Tuberculosis
 Miscellaneous
 Sarcoidosis
 Malignancies
 Aging
Radiology
 Evaluate disease activity & joint
damage
 Bony decalcification
Radiological Studies
 Plain Films
Bilateral hands & feet
 Color Doppler U/S & MRI
Early signs of damage i.e. Erosions
Bone Edema - even with normal
findings on radiography
DISEASE
SEVERITY
Mild Disease
 Arthralgias
 >3 inflamed joints
 Mild functional limitation
 Minimally elevated ESR & CRP
 No erosions/cartilage loss
 No extraarticular disease
Moderate Disease
 6-20 Inflamed joints
 Moderate functional limitation
 Elevated ESR/CRP
 Radiographic evidence of
inflammation
 No extraarticular disease
Severe Disease
 >20 persistently inflamed joints
 Rapid decline in functional capacity
 Radiographic evidence of rapid
progession of bony erosions & loss of
cartilage
 Extraarticular disease
bad prognostic Features
 RF +ve
 Early development of multiple inflamed
joints and joint erosions
 Severe functional limitation
 Female
 HLA epitope presence
 Lower socioeconomic status & Less
education
 Persistent joint inflammation for >12
weeks
Differential diagnosis of arthritis
 Seronegative polyarthritis
 Psoriatic arthritis
 Osteoarthritis
 SLE
 Paraneoplastic syndrome
 Crystal-induced arthritis
Tophaceous gout
Pseudogout
Rheumatoid arthritis.ppt

More Related Content

What's hot

Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
Dr.Anees Kurikkal
 
Pathophysiology of Rheumatoid Arthritis
Pathophysiology of  Rheumatoid ArthritisPathophysiology of  Rheumatoid Arthritis
Pathophysiology of Rheumatoid Arthritis
Nem kumar Jain
 
Rheumatois arthritis , pain management..
Rheumatois arthritis , pain management..Rheumatois arthritis , pain management..
Rheumatois arthritis , pain management..
Dr Ravi Shankar Sharma
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
Syed Muhammad Ali Shah
 
Rheumatoid arthritis for undergraduates
Rheumatoid arthritis for undergraduatesRheumatoid arthritis for undergraduates
Rheumatoid arthritis for undergraduatesDhananjaya Sabat
 
Arthritis
ArthritisArthritis
Arthritis
drangelosmith
 
RHEUMATOID ARTHRITIS
RHEUMATOID ARTHRITISRHEUMATOID ARTHRITIS
RHEUMATOID ARTHRITIS
aishuanju
 
Rheumatoid Arthritis.pptx
Rheumatoid Arthritis.pptxRheumatoid Arthritis.pptx
Rheumatoid Arthritis.pptx
ssuserdbec94
 
rheumatoid arthritis.ppt
rheumatoid arthritis.pptrheumatoid arthritis.ppt
rheumatoid arthritis.ppt
Minella4
 
Osteoarthritis and Rheumatoid Arthritis
Osteoarthritis and Rheumatoid Arthritis Osteoarthritis and Rheumatoid Arthritis
Osteoarthritis and Rheumatoid Arthritis
Rifhan Kamaruddin
 
Rheumatoid arthritis current diagnosis and treatment
Rheumatoid arthritis current diagnosis and treatmentRheumatoid arthritis current diagnosis and treatment
Rheumatoid arthritis current diagnosis and treatment
Ankur Varshney
 
Psoriatic arthritis
Psoriatic arthritis Psoriatic arthritis
Psoriatic arthritis
Dinoosh De Livera
 
RHEUMATOID ARTHRITIS
RHEUMATOID ARTHRITISRHEUMATOID ARTHRITIS
RHEUMATOID ARTHRITISshruti87
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
keerthi samuel
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
Baljinder Singh
 
Osteoarthritis 2021 Updated Guidelines
Osteoarthritis 2021 Updated GuidelinesOsteoarthritis 2021 Updated Guidelines
Osteoarthritis 2021 Updated Guidelines
Dr. Aryan (Anish Dhakal)
 
Rheumatoid Arthritis
Rheumatoid ArthritisRheumatoid Arthritis
Rheumatoid Arthritis
Gajanan Pandit
 
rheumatoid arthritis
rheumatoid arthritisrheumatoid arthritis
rheumatoid arthritis
Ashwini Somayaji
 

What's hot (20)

Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Pathophysiology of Rheumatoid Arthritis
Pathophysiology of  Rheumatoid ArthritisPathophysiology of  Rheumatoid Arthritis
Pathophysiology of Rheumatoid Arthritis
 
Management of rheumatoid arthritis .by Dr.Harmanjit Singh,GMC, Patiala
Management of rheumatoid arthritis .by Dr.Harmanjit Singh,GMC, PatialaManagement of rheumatoid arthritis .by Dr.Harmanjit Singh,GMC, Patiala
Management of rheumatoid arthritis .by Dr.Harmanjit Singh,GMC, Patiala
 
Rheumatois arthritis , pain management..
Rheumatois arthritis , pain management..Rheumatois arthritis , pain management..
Rheumatois arthritis , pain management..
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Gout management
Gout managementGout management
Gout management
 
Rheumatoid arthritis for undergraduates
Rheumatoid arthritis for undergraduatesRheumatoid arthritis for undergraduates
Rheumatoid arthritis for undergraduates
 
Arthritis
ArthritisArthritis
Arthritis
 
RHEUMATOID ARTHRITIS
RHEUMATOID ARTHRITISRHEUMATOID ARTHRITIS
RHEUMATOID ARTHRITIS
 
Rheumatoid Arthritis.pptx
Rheumatoid Arthritis.pptxRheumatoid Arthritis.pptx
Rheumatoid Arthritis.pptx
 
rheumatoid arthritis.ppt
rheumatoid arthritis.pptrheumatoid arthritis.ppt
rheumatoid arthritis.ppt
 
Osteoarthritis and Rheumatoid Arthritis
Osteoarthritis and Rheumatoid Arthritis Osteoarthritis and Rheumatoid Arthritis
Osteoarthritis and Rheumatoid Arthritis
 
Rheumatoid arthritis current diagnosis and treatment
Rheumatoid arthritis current diagnosis and treatmentRheumatoid arthritis current diagnosis and treatment
Rheumatoid arthritis current diagnosis and treatment
 
Psoriatic arthritis
Psoriatic arthritis Psoriatic arthritis
Psoriatic arthritis
 
RHEUMATOID ARTHRITIS
RHEUMATOID ARTHRITISRHEUMATOID ARTHRITIS
RHEUMATOID ARTHRITIS
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Osteoarthritis 2021 Updated Guidelines
Osteoarthritis 2021 Updated GuidelinesOsteoarthritis 2021 Updated Guidelines
Osteoarthritis 2021 Updated Guidelines
 
Rheumatoid Arthritis
Rheumatoid ArthritisRheumatoid Arthritis
Rheumatoid Arthritis
 
rheumatoid arthritis
rheumatoid arthritisrheumatoid arthritis
rheumatoid arthritis
 

Similar to Rheumatoid arthritis.ppt

final_rheumatoid_arthritis.ppt
final_rheumatoid_arthritis.pptfinal_rheumatoid_arthritis.ppt
final_rheumatoid_arthritis.ppt
Anas995288
 
Approach To A Patient With Polyarthritis
Approach To A Patient With PolyarthritisApproach To A Patient With Polyarthritis
Approach To A Patient With PolyarthritisPramod Mahender
 
Rhematoid arthritis by dr shyam sunder sharma
Rhematoid arthritis by dr shyam sunder sharmaRhematoid arthritis by dr shyam sunder sharma
Rhematoid arthritis by dr shyam sunder sharma
drshyamsundersharma
 
Rheumatoid arthritis.pptx
Rheumatoid arthritis.pptxRheumatoid arthritis.pptx
Rheumatoid arthritis.pptx
HudaSaber1
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritisRatan Khuman
 
6256667.ppt
6256667.ppt6256667.ppt
6256667.ppt
HamdiAlaqal
 
د.عبدالله شاكر Rheumatoid Arthritis-15 (Muhadharaty).ppt
د.عبدالله شاكر Rheumatoid Arthritis-15 (Muhadharaty).pptد.عبدالله شاكر Rheumatoid Arthritis-15 (Muhadharaty).ppt
د.عبدالله شاكر Rheumatoid Arthritis-15 (Muhadharaty).ppt
RezaAbdullahi
 
بحث الدكتور سليم.pptx
بحث الدكتور سليم.pptxبحث الدكتور سليم.pptx
بحث الدكتور سليم.pptx
HamdiAlaqal
 
RHEUMATOID ARTHRITIS.pptx
RHEUMATOID ARTHRITIS.pptxRHEUMATOID ARTHRITIS.pptx
RHEUMATOID ARTHRITIS.pptx
Ameena Kadar
 
rheumatoid arthritis,gout & osteoarthritis
rheumatoid arthritis,gout & osteoarthritisrheumatoid arthritis,gout & osteoarthritis
rheumatoid arthritis,gout & osteoarthritis
dr.shameer basha
 
inflammatoryarthritis-170820154705 (1).pdf
inflammatoryarthritis-170820154705 (1).pdfinflammatoryarthritis-170820154705 (1).pdf
inflammatoryarthritis-170820154705 (1).pdf
Rohit778715
 
Rheumatoid arthritis
Rheumatoid arthritis Rheumatoid arthritis
Rheumatoid arthritis
EDWINjose43
 
Ra dr s alam
Ra  dr s alamRa  dr s alam
Ra dr s alam
wasek_bd
 
ra-2013-final.pptx
ra-2013-final.pptxra-2013-final.pptx
ra-2013-final.pptx
AbdelrahmanElBady1
 
Ra
RaRa
RA undergraduates
RA undergraduatesRA undergraduates
RHEUMATOID ARTHRITIS by ershard ali.pptx
RHEUMATOID ARTHRITIS by ershard ali.pptxRHEUMATOID ARTHRITIS by ershard ali.pptx
RHEUMATOID ARTHRITIS by ershard ali.pptx
ershadali534
 

Similar to Rheumatoid arthritis.ppt (20)

final_rheumatoid_arthritis.ppt
final_rheumatoid_arthritis.pptfinal_rheumatoid_arthritis.ppt
final_rheumatoid_arthritis.ppt
 
Approach To A Patient With Polyarthritis
Approach To A Patient With PolyarthritisApproach To A Patient With Polyarthritis
Approach To A Patient With Polyarthritis
 
Arthritis
ArthritisArthritis
Arthritis
 
ARTHRITIS.pptx
ARTHRITIS.pptxARTHRITIS.pptx
ARTHRITIS.pptx
 
Rhematoid arthritis by dr shyam sunder sharma
Rhematoid arthritis by dr shyam sunder sharmaRhematoid arthritis by dr shyam sunder sharma
Rhematoid arthritis by dr shyam sunder sharma
 
Rheumatoid arthritis.pptx
Rheumatoid arthritis.pptxRheumatoid arthritis.pptx
Rheumatoid arthritis.pptx
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
6256667.ppt
6256667.ppt6256667.ppt
6256667.ppt
 
د.عبدالله شاكر Rheumatoid Arthritis-15 (Muhadharaty).ppt
د.عبدالله شاكر Rheumatoid Arthritis-15 (Muhadharaty).pptد.عبدالله شاكر Rheumatoid Arthritis-15 (Muhadharaty).ppt
د.عبدالله شاكر Rheumatoid Arthritis-15 (Muhadharaty).ppt
 
بحث الدكتور سليم.pptx
بحث الدكتور سليم.pptxبحث الدكتور سليم.pptx
بحث الدكتور سليم.pptx
 
RHEUMATOID ARTHRITIS.pptx
RHEUMATOID ARTHRITIS.pptxRHEUMATOID ARTHRITIS.pptx
RHEUMATOID ARTHRITIS.pptx
 
rheumatoid arthritis,gout & osteoarthritis
rheumatoid arthritis,gout & osteoarthritisrheumatoid arthritis,gout & osteoarthritis
rheumatoid arthritis,gout & osteoarthritis
 
inflammatoryarthritis-170820154705 (1).pdf
inflammatoryarthritis-170820154705 (1).pdfinflammatoryarthritis-170820154705 (1).pdf
inflammatoryarthritis-170820154705 (1).pdf
 
Inflammatory arthritis
Inflammatory arthritisInflammatory arthritis
Inflammatory arthritis
 
Rheumatoid arthritis
Rheumatoid arthritis Rheumatoid arthritis
Rheumatoid arthritis
 
Ra dr s alam
Ra  dr s alamRa  dr s alam
Ra dr s alam
 
ra-2013-final.pptx
ra-2013-final.pptxra-2013-final.pptx
ra-2013-final.pptx
 
Ra
RaRa
Ra
 
RA undergraduates
RA undergraduatesRA undergraduates
RA undergraduates
 
RHEUMATOID ARTHRITIS by ershard ali.pptx
RHEUMATOID ARTHRITIS by ershard ali.pptxRHEUMATOID ARTHRITIS by ershard ali.pptx
RHEUMATOID ARTHRITIS by ershard ali.pptx
 

More from KeyaArere

PHARMACOLGY I-Lecturer 2a notes h-1.pptx
PHARMACOLGY I-Lecturer 2a notes h-1.pptxPHARMACOLGY I-Lecturer 2a notes h-1.pptx
PHARMACOLGY I-Lecturer 2a notes h-1.pptx
KeyaArere
 
5. PHARMACOLOGY II (1).pptx Analgesic and nsaids
5. PHARMACOLOGY II (1).pptx Analgesic and nsaids5. PHARMACOLOGY II (1).pptx Analgesic and nsaids
5. PHARMACOLOGY II (1).pptx Analgesic and nsaids
KeyaArere
 
ORTHOPEDIC CONDITIONS-2-1 infections.pptx
ORTHOPEDIC  CONDITIONS-2-1 infections.pptxORTHOPEDIC  CONDITIONS-2-1 infections.pptx
ORTHOPEDIC CONDITIONS-2-1 infections.pptx
KeyaArere
 
UE 9 Radial Head and Neck Fractures. pdf
UE 9 Radial Head and Neck Fractures. pdfUE 9 Radial Head and Neck Fractures. pdf
UE 9 Radial Head and Neck Fractures. pdf
KeyaArere
 
Amino glycosides and streptomycin pharmac
Amino glycosides and streptomycin pharmacAmino glycosides and streptomycin pharmac
Amino glycosides and streptomycin pharmac
KeyaArere
 
REHABILITATION.pptx
REHABILITATION.pptxREHABILITATION.pptx
REHABILITATION.pptx
KeyaArere
 
8. PHARMACOLOGY II-1.pdf
8. PHARMACOLOGY II-1.pdf8. PHARMACOLOGY II-1.pdf
8. PHARMACOLOGY II-1.pdf
KeyaArere
 
scrubbinggowningandglovingtechnique-lennah.pdf
scrubbinggowningandglovingtechnique-lennah.pdfscrubbinggowningandglovingtechnique-lennah.pdf
scrubbinggowningandglovingtechnique-lennah.pdf
KeyaArere
 
Mobility Aids and Positioning-1.pdf
Mobility Aids and Positioning-1.pdfMobility Aids and Positioning-1.pdf
Mobility Aids and Positioning-1.pdf
KeyaArere
 
Spine Orthotics-1.pdf
Spine Orthotics-1.pdfSpine Orthotics-1.pdf
Spine Orthotics-1.pdf
KeyaArere
 
Spine Biomechanics-1.pdf
Spine Biomechanics-1.pdfSpine Biomechanics-1.pdf
Spine Biomechanics-1.pdf
KeyaArere
 
THE DIGESTIVE SYSTEM [Autosaved].pptx
THE DIGESTIVE SYSTEM [Autosaved].pptxTHE DIGESTIVE SYSTEM [Autosaved].pptx
THE DIGESTIVE SYSTEM [Autosaved].pptx
KeyaArere
 
ORGANIZATION OF HEALTH CARE SERVICES-1.ppt
ORGANIZATION OF HEALTH CARE SERVICES-1.pptORGANIZATION OF HEALTH CARE SERVICES-1.ppt
ORGANIZATION OF HEALTH CARE SERVICES-1.ppt
KeyaArere
 
OFA 2021.pptx
OFA 2021.pptxOFA 2021.pptx
OFA 2021.pptx
KeyaArere
 
Adverse Reactions.ppt
Adverse Reactions.pptAdverse Reactions.ppt
Adverse Reactions.ppt
KeyaArere
 
EOral-Obesity.ppt
EOral-Obesity.pptEOral-Obesity.ppt
EOral-Obesity.ppt
KeyaArere
 
Drug interactions.ppt
Drug interactions.pptDrug interactions.ppt
Drug interactions.ppt
KeyaArere
 
diploma HEALTH SYSTEM MANAGEMENT.pptx
diploma HEALTH SYSTEM MANAGEMENT.pptxdiploma HEALTH SYSTEM MANAGEMENT.pptx
diploma HEALTH SYSTEM MANAGEMENT.pptx
KeyaArere
 
Parmacodynamics.pptx
Parmacodynamics.pptxParmacodynamics.pptx
Parmacodynamics.pptx
KeyaArere
 
DIPLOMA OTM HSM1.ppt
DIPLOMA OTM HSM1.pptDIPLOMA OTM HSM1.ppt
DIPLOMA OTM HSM1.ppt
KeyaArere
 

More from KeyaArere (20)

PHARMACOLGY I-Lecturer 2a notes h-1.pptx
PHARMACOLGY I-Lecturer 2a notes h-1.pptxPHARMACOLGY I-Lecturer 2a notes h-1.pptx
PHARMACOLGY I-Lecturer 2a notes h-1.pptx
 
5. PHARMACOLOGY II (1).pptx Analgesic and nsaids
5. PHARMACOLOGY II (1).pptx Analgesic and nsaids5. PHARMACOLOGY II (1).pptx Analgesic and nsaids
5. PHARMACOLOGY II (1).pptx Analgesic and nsaids
 
ORTHOPEDIC CONDITIONS-2-1 infections.pptx
ORTHOPEDIC  CONDITIONS-2-1 infections.pptxORTHOPEDIC  CONDITIONS-2-1 infections.pptx
ORTHOPEDIC CONDITIONS-2-1 infections.pptx
 
UE 9 Radial Head and Neck Fractures. pdf
UE 9 Radial Head and Neck Fractures. pdfUE 9 Radial Head and Neck Fractures. pdf
UE 9 Radial Head and Neck Fractures. pdf
 
Amino glycosides and streptomycin pharmac
Amino glycosides and streptomycin pharmacAmino glycosides and streptomycin pharmac
Amino glycosides and streptomycin pharmac
 
REHABILITATION.pptx
REHABILITATION.pptxREHABILITATION.pptx
REHABILITATION.pptx
 
8. PHARMACOLOGY II-1.pdf
8. PHARMACOLOGY II-1.pdf8. PHARMACOLOGY II-1.pdf
8. PHARMACOLOGY II-1.pdf
 
scrubbinggowningandglovingtechnique-lennah.pdf
scrubbinggowningandglovingtechnique-lennah.pdfscrubbinggowningandglovingtechnique-lennah.pdf
scrubbinggowningandglovingtechnique-lennah.pdf
 
Mobility Aids and Positioning-1.pdf
Mobility Aids and Positioning-1.pdfMobility Aids and Positioning-1.pdf
Mobility Aids and Positioning-1.pdf
 
Spine Orthotics-1.pdf
Spine Orthotics-1.pdfSpine Orthotics-1.pdf
Spine Orthotics-1.pdf
 
Spine Biomechanics-1.pdf
Spine Biomechanics-1.pdfSpine Biomechanics-1.pdf
Spine Biomechanics-1.pdf
 
THE DIGESTIVE SYSTEM [Autosaved].pptx
THE DIGESTIVE SYSTEM [Autosaved].pptxTHE DIGESTIVE SYSTEM [Autosaved].pptx
THE DIGESTIVE SYSTEM [Autosaved].pptx
 
ORGANIZATION OF HEALTH CARE SERVICES-1.ppt
ORGANIZATION OF HEALTH CARE SERVICES-1.pptORGANIZATION OF HEALTH CARE SERVICES-1.ppt
ORGANIZATION OF HEALTH CARE SERVICES-1.ppt
 
OFA 2021.pptx
OFA 2021.pptxOFA 2021.pptx
OFA 2021.pptx
 
Adverse Reactions.ppt
Adverse Reactions.pptAdverse Reactions.ppt
Adverse Reactions.ppt
 
EOral-Obesity.ppt
EOral-Obesity.pptEOral-Obesity.ppt
EOral-Obesity.ppt
 
Drug interactions.ppt
Drug interactions.pptDrug interactions.ppt
Drug interactions.ppt
 
diploma HEALTH SYSTEM MANAGEMENT.pptx
diploma HEALTH SYSTEM MANAGEMENT.pptxdiploma HEALTH SYSTEM MANAGEMENT.pptx
diploma HEALTH SYSTEM MANAGEMENT.pptx
 
Parmacodynamics.pptx
Parmacodynamics.pptxParmacodynamics.pptx
Parmacodynamics.pptx
 
DIPLOMA OTM HSM1.ppt
DIPLOMA OTM HSM1.pptDIPLOMA OTM HSM1.ppt
DIPLOMA OTM HSM1.ppt
 

Recently uploaded

Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
Steve Thomason
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
bennyroshan06
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
rosedainty
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
GeoBlogs
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
PedroFerreira53928
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Introduction to Quality Improvement Essentials
Introduction to Quality Improvement EssentialsIntroduction to Quality Improvement Essentials
Introduction to Quality Improvement Essentials
Excellence Foundation for South Sudan
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 

Recently uploaded (20)

Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Introduction to Quality Improvement Essentials
Introduction to Quality Improvement EssentialsIntroduction to Quality Improvement Essentials
Introduction to Quality Improvement Essentials
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 

Rheumatoid arthritis.ppt

  • 2. Learning objectives:  At the end of this lecture the student should be able to :  understand definition,genetic predisposition of RA.  Discuss pathophysiology, clinical features of RA.  Identify Diagnostic Criteria ,Laboratory Features and bad prognostic Features of Rheumatoid Arthritis.
  • 3. Definition  Rheumatoid arthritis (RA) is a chronic systemic inflammatory disorder that may affect many tissues and organs—skin, blood vessels, heart, lungs, and muscles—but principally attacks the joints, producing a non-suppurative proliferative and inflammatory synovitis that often progresses to destruction of the articular cartilage and ankylosis of the joints.
  • 4.  Although the cause of RA remains unknown, autoimmunity plays a pivotal role in its chronicity and progression.  About 1% of the world's population is afflicted by RA, women two to three times more often than men.
  • 5.  It is most common in those age 40 to 70, but no age is immune.  It is a systemic inflammatory autoimmune disorder
  • 6. Genetics  Patients who have HLA-DRB have Increased risk for : RA development. Increased joint damage Increased joint need for surgery
  • 8. Role of Immunology in RA  Macrophages: Produce cytokines Cytokines (TNF-α) cause systemic features Release chemokines  recruit PMNs into synovial fluid/membrane
  • 9.  TNF-α & IL-1: Proliferation of T cells Activation of B cells Initiates pro-inflammatory/joint-damaging processes
  • 10.  TH-1 cells: Mediate disease processes Activate B cells  B cells: Release cytokines Plasma cells that produce Ab
  • 11.  Osteoclasts induce: Bone erosion Juxta-articular & Systemic osteoporosis
  • 12. Pathophysiology  Swelling of Synovial lining  Angiogenesis  Pannus formation in form of :  Synovial thickening/hyperplasia  Inflammatory vascularized tissue  Generation of Metalloproteinases  Cytokine release  Infiltration of leukocytes  Change in cell-surface adhesion molecules & cytokines  Destruction of bone & cartilage
  • 13.
  • 14. Sequence of events :  Proliferation of synovial membrane cells with inflammatory cell infiltrate  Destruction of joints  Disability
  • 16. 1- Diagnostic Criteria  Symmetric peripheral polyarthritis  Morning Stiffness >1 hour  Extra-articular manifestations  Rheumatoid nodules
  • 17. Symmetric Peripheral Polyarthritis  3 or more Joints for >6 weeks  Intermittent or Migratory involvement  Small Joints Hands & Feet Peripheral to Proximal  Leads to Deformity & Destruction of Joints Erosion of cartilage and bone
  • 18. Stiffness  Morning or after Prolonged Inactivity  Bilateral  > 1 hours Reflects severe joint inflammation  Better with movement  Pain with pressure to joint
  • 19. ….Stiffness  Pain with movement of joint  Swelling due to hypertrophy of synovium  Effusion  Hotness  Redness
  • 20. Physical Exam  Decreased grip strength  Carpal tunnel syndrome(condition characterized by pain and numbing or tingling sensations in the hand and caused by compression of a nerve in the carpal tunnel at the wrist.  Ulnar deviation  Boutonniere/Swan neck deformities  Extensor tendon rupture
  • 21.
  • 22.
  • 23. Extraarticular Involvement  Myalgia, fatigue, low-grade fever, weight loss, depression.  Anemia  Rheumatoid nodules  Pleuro-pericarditis
  • 24.  Neuropathy  Sicca features: Xerostomia & Xerophthalmia  Scleritis  Splenomegaly  Vasculitis
  • 26. Rheumatoid Nodules  Extensor surfaces  elbows  Very Specific  Only occur in ~30%  Late in Disease
  • 29. Arthrocentesis  Confirm diagnoses  Differentiate between inflammatory & non-inflammatory  Labs: White blood cell count if WBC >2000/µL indicates inflammatory arthritis Gram stain & Culture
  • 30.  Arthroscopy Evaluate ligamentous & cartilaginous integrity Biopsy Infection: aspirate thick
  • 31. Rheumatoid arthritis : showing inflammatory cell infiltrate in the synovium
  • 32. Laboratory findings  Anemia of moderate degree  ESR  a useful parameter for assessing response to therapy  C-reactive protein   RF (usually IgM)  CIC  , complements   ANA  Anti-CCP (cyclic citrullinated peptide)
  • 33. Rheumatoid Factor  Antibodies to Fc portion of IgG  75-80% of Patients have during course of disease  Useful for prognosis
  • 34. Rheumatoid Factor  IgG Molecule  Fc Portion Antigen Binding Groove Autoantibodies (IgM) directed against the Fc Fragment of IgG An Antibody to an Antibody Their Role in RA is not understood
  • 35. Rheumatoid Factor  RFs are human auto-Abs that react with the Fc portion of normal polyclonal IgG.  Most routine clinical assays for RF detect only IgM RFs, although RFs can be any class of immunoglobulin  Named thus because their first description was in patients with rheumatoid arthritis
  • 36. Rheumatoid Factor  RF test is approximately 65%-75% sensitive for the diagnosis  The presence of RF, even in high titers or large amounts, is not specific for RA
  • 37. Condition Assoc . With(+) Tests for RF  Rheumatologic Diseases  Rheumatoid arthritis (~70%)  Sjögren’s syndrome (~90%)  Lupus (~20%)  Cryoglobulinemia syndrome (90%)  Lung Diseases  Interstitial fibrosis  Silicosis
  • 38.  Infections  Hepatitis C virus  Acute viral infections  Endocarditis  Tuberculosis  Miscellaneous  Sarcoidosis  Malignancies  Aging
  • 39. Radiology  Evaluate disease activity & joint damage  Bony decalcification
  • 40. Radiological Studies  Plain Films Bilateral hands & feet  Color Doppler U/S & MRI Early signs of damage i.e. Erosions Bone Edema - even with normal findings on radiography
  • 41.
  • 42.
  • 44. Mild Disease  Arthralgias  >3 inflamed joints  Mild functional limitation  Minimally elevated ESR & CRP  No erosions/cartilage loss  No extraarticular disease
  • 45. Moderate Disease  6-20 Inflamed joints  Moderate functional limitation  Elevated ESR/CRP  Radiographic evidence of inflammation  No extraarticular disease
  • 46. Severe Disease  >20 persistently inflamed joints  Rapid decline in functional capacity  Radiographic evidence of rapid progession of bony erosions & loss of cartilage  Extraarticular disease
  • 47. bad prognostic Features  RF +ve  Early development of multiple inflamed joints and joint erosions  Severe functional limitation  Female  HLA epitope presence  Lower socioeconomic status & Less education  Persistent joint inflammation for >12 weeks
  • 48. Differential diagnosis of arthritis  Seronegative polyarthritis  Psoriatic arthritis  Osteoarthritis  SLE  Paraneoplastic syndrome  Crystal-induced arthritis Tophaceous gout Pseudogout